Publication: Regional differences in STEMI care in Spain. Data from the ACI-SEC Infarction Code Registry
Loading...
Identifiers
ISSN: 2604-7322
Full text access: https://hdl.handle.net/20.500.13003/20101
SCOPUS: 2-s2.0-85172018384
Publication date
Advisors
Journal Title
Journal ISSN
Volume Title
Publishers
Permanyer
Abstract
Introduction and objectives: Geographical and organizational differences between different autonomous communities (AC) can generate differences in care for ST-segment elevation myocardial infarction (STEMI). A total of 17 heart attack code programs have been compared in terms of incidence rate, clinical characteristics, reperfusion therapy, delay to reperfusion, and 30-day mortality. Methods: National prospective observational study (83 centers included in 17 infarction networks). The recruitment period was 3 months (April 1 to June 30, 2019) with clinical follow-up at 30 days. Results: 4366 patients with STEMI were included. The incidence rate was variable between different AC (P < .0001), as was gender (P = .003) and the prevalence of cardiovascular risk factors (P < .0001). Reperfusion treatment was primary angioplasty (range 77.5%-97.8%), fibrinolysis (range 0%-12.9%) or no treatment (range 2.2%- 13.5%). The analysis of the delay to reperfusion showed significant differences (P < .001) for all the intervals analyzed. There were significant differences in 30-days mortality that disappeared after adjusting for clinical and healthcare network characteristics. Conclusions: Large differences in STEMI care have been detected between the different AC, in terms of incidence rate, clinical characteristics, reperfusion treatment, delay until reperfusion, and 30-day mortality. The differences in mortality disappeared after adjusting for the characteristics of the patient and the care network.
Description
Keywords
MeSH Terms
DeCS Terms
Bibliographic citation
REC Interv Cardiol. 2023;5(2):118-128
Collections
Grupos de investigación
IBSAL - Instituto de Investigación Biómedica de Salamanca (Castilla y León)
IDIBELL - Instituto de Investigación Biomédica de Bellvitge (Cataluña)
IdisBa - Instituto de Investigación Sanitaria Illes Balears (Baleares)
IGTP - Instituto de Investigación en Ciencias de la Salud Germans Trias i Pujol (Cataluña)
IIS-FJD - Instituto de Investigación Sanitaria Fundación Jiménez Díaz (Madrid)
Load more IBSAL - Instituto de Investigación Biómedica de Salamanca (Castilla y León)
IDIBELL - Instituto de Investigación Biomédica de Bellvitge (Cataluña)
IdisBa - Instituto de Investigación Sanitaria Illes Balears (Baleares)
IGTP - Instituto de Investigación en Ciencias de la Salud Germans Trias i Pujol (Cataluña)
IIS-FJD - Instituto de Investigación Sanitaria Fundación Jiménez Díaz (Madrid)





